Legal Proceedings
−Removed: On January 19, 2024, a purported shareholder class
−Removed: action complaint, captioned Eric Olmstead v.
+Added: On January 19, 2024, a purported shareholder
+Added: class action complaint, captioned Eric Olmstead v.
3:24-cv-00035, was filed in the U.S.
−Removed: District Court for the
−Removed: District of Nevada, naming BioVie Inc.
−Removed: (the “Company”) and certain of its officers and/or directors as defendants.
−Removed: alleges that the Company made material misrepresentations and/or omissions of material fact relating to the Company’s business,
−Removed: operations, compliance, and prospects, including information related to the study and trial of NE3107, in
−Removed: violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder.
−Removed: action is on behalf of purchasers of the Company’s securities during the period from August 5, 2021 through November 29, 2023 and
−Removed: seeks unspecified monetary damages on behalf of the putative class and an award of costs and expenses, including attorney’s fees.
+Added: Court for the District of Nevada, naming the Company and certain of its officers and/or directors as defendants.
+Added: On April 15, 2024
+Added: the court ordered the motion to consolidate the six pending motions, appointed the lead plaintiff and approved selection of the lead
+Added: counsel, now captioned Olmstead v.
+Added: BioVie Inc., et al., Case 3:24-cv-0035 LRH-CSD and Way v.
+Added: BioVie Inc., et al., Case No.
+Added: 2:24-cv-00361-LRH-CSD.
+Added: The lawsuit alleges that the Company made material misrepresentations and/or omissions of material fact
+Added: relating to the Company’s business, operations, compliance, and prospects, including information related to the study and
+Added: trial of NE3107, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of
+Added: 1934, as amended, and Rule 10b-5 promulgated thereunder.
+Added: The class action is on behalf of purchasers of the Company’s
+Added: securities during the period from August 5, 2021 through November 29, 2023 and seeks unspecified monetary damages on behalf of the
+Added: putative class and an award of costs and expenses, including attorney’s fees.
The Company believes the lawsuit is without merit
2 unchanged sentences
the outcome of the litigation.
−Removed: There are no other judgments against us or our
−Removed: officers or directors.
−Removed: None of our officers or directors has been convicted of a felony or misdemeanor relating to securities or performance
−Removed: in corporate office.
+Added: There are no other judgments against us or our officers
+Added: or directors.
+Added: None of our officers or directors has been convicted of a felony or misdemeanor relating to securities or performance in
+Added: corporate office.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.